CONMED Profit Margin 2010-2025 | CNMD

Current and historical gross margin, operating margin and net profit margin for CONMED (CNMD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. CONMED net profit margin as of March 31, 2025 is 9.02%.
CONMED Annual Profit Margins
CONMED Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $1.766B $1.307B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $89.096B 21.51
Becton Dickinson (BDX) United States $49.586B 12.28
Cardinal Health (CAH) United States $36.549B 19.14
Labcorp (LH) United States $20.676B 16.77
Straumann Holding AG (SAUHY) Switzerland $20.594B 0.00
Cooper (COO) United States $16.022B 21.25
West Pharmaceutical Services (WST) United States $15.187B 31.84
Align Technology (ALGN) United States $13.055B 25.92
Henry Schein (HSIC) United States $8.934B 15.32
Merit Medical Systems (MMSI) United States $5.581B 26.98
DENTSPLY SIRONA (XRAY) United States $3.290B 9.83
STAAR Surgical (STAA) United States $0.895B 0.00
Lifevantage (LFVN) United States $0.160B 16.51
Pro-Dex (PDEX) United States $0.135B 14.75